Save time and get answers to complex questions with AI chat
Novartis patent term dabrafenib?Patent expiration eu dabrafenib?Is clarinex off patent?Dabrafenib btd date 2023?Drug patent watch trametinib?
See the DrugPatentWatch profile for Qelbree
Qelbree is the brand name for viloxazine. It’s an ADHD medication. - Indication: FDA-approved for treating attention-deficit/hyperactivity disorder (ADHD) in children and adolescents aged 6 to 17 years. Not approved for adults as of the latest labeling. - Type: A non-stimulant, extended-release capsule. It’s a norepinephrine reuptake inhibitor–like medication. - How it’s used: Taken orally once daily (dosed and titrated by a clinician, up to a typical maximum around 400 mg/day). Can be taken with or without food. - When it helps: Symptoms may improve over several weeks; it’s often used when stimulants are not suitable or cause intolerable side effects. - Other notes: It’s part of a broader ADHD treatment plan that may include behavioral therapy. Always follow your clinician’s dosing guidance and monitor for side effects. If you’re asking about a specific patient (age, other conditions, current meds), I can tailor the details.
Other Questions About Qelbree :